Referral Characteristics of Palliative Care Service in Patients With Advanced Non-Small Cell Lung Cancer in a Tertiary Cancer Center

• Published in: American journal of hospice & palliative medicine Vol. 37; no. 4; p. 266
• Main Authors: Gu, Xiaoli, Chen, Menglei, Liu, Minghui, Zhang, Zhe, Zhao, Weiwei, Cheng, Wenwu
• Format: Journal Article
• Language: English
• Published: United States 01.04.2020
• Subjects: Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung - epidemiology; Carcinoma, Non-Small-Cell Lung - mortality; Carcinoma, Non-Small-Cell Lung - pathology; China - epidemiology; Female; Humans; Lung Neoplasms - epidemiology; Lung Neoplasms - mortality; Lung Neoplasms - pathology; Male; Middle Aged; Neoplasm Staging; Palliative Care - statistics & numerical data; Referral and Consultation - statistics & numerical data; Retrospective Studies; Socioeconomic Factors; Tertiary Care Centers - statistics & numerical data; Time Factors; China; overall survival; symptom management; advanced non-small cell lung cancer; early palliative care; predictors for early palliative care; timing of referral
• ISSN: 1938-2715
• DOI: 10.1177/1049909119867281

The American Society of Clinical Oncology recently recommends patients with metastatic non-small cell lung cancer (NSCLC) should be offered palliative care services earlier. We sought to investigate the timing of palliative care referral of Chinese patients with NSCLC in our center. Retrospective medical data including demographic characteristics and referral information were collected for analysis. Overall survival (OS) was calculated as the time since cancer diagnosis till patient's death. The time interval from palliative care (PC) referral to a patient's death (PC-D) was calculated. The PC-D/OS ratio was calculated to illustrate the comparison of the duration of PC in the overall length of disease. The mean age of 155 patients with advanced NSCLC was 62.83 years. Before referral to PC, 128 patients received anticancer treatment including surgeon (46.5%). Sixty-three (40.6%) patients died in palliative care unit. The median OS of 144 patients with end cutoff was 19 months (mean = 31.49, 95% confidence interval [CI] = 25.86-37.12). The median PC-D was 41 days (mean = 73.84, 95% CI = 60.37-87.40). The mean interval of PC-D/OS of 144 patients with definitely death time was 0.22 (SD: 0.27, 95% CI: 0.17-0.26). The median interval was 0.089. More than half of patients (n = 75, 51.8%) underwent PC less than 1% time (PC-D/OS < 0.1) of their whole disease course. Patients who were indigenous to Shanghai ( = .013) and who had brain metastasis ( = .072) had the potential longer PC-D/OS ratio. A high proportion of patients reported loss of appetite (92.8%) and fatigue (91.4%) at the initial of referral to PC. This retrospective study, in a population of patients with advanced NSCLC, gave detailed information about PC services in a tertiary cancer center.